What is a stock summary page? Click here for an overview.
Business Description
Encision Inc
NAICS : 339112
SIC : 3841
ISIN : US29254Q1040
Description
Encision Inc is a medical device company. The company develops and markets technology that provides unprecedented outcomes and patient safety in minimally invasive surgery. The company has established and developed AEM (Active Electrode Monitoring) technology and surgical instruments which provide surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death. The segments of the company are Product and Service. Product designs develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities. Maximum revenue is generated from the product segment.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.27 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.78 | |||||
| Debt-to-EBITDA | -3.33 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -5.06 | |||||
| Beneish M-Score | -3.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -4.4 | |||||
| 3-Year EPS without NRI Growth Rate | -291.5 | |||||
| 3-Year FCF Growth Rate | -15.7 | |||||
| 3-Year Book Growth Rate | -14 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 15.85 | |||||
| 9-Day RSI | 42.04 | |||||
| 14-Day RSI | 50.4 | |||||
| 3-1 Month Momentum % | 8.89 | |||||
| 6-1 Month Momentum % | 25.64 | |||||
| 12-1 Month Momentum % | -30 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.67 | |||||
| Quick Ratio | 0.82 | |||||
| Cash Ratio | 0.22 | |||||
| Days Inventory | 155.51 | |||||
| Days Sales Outstanding | 47.49 | |||||
| Days Payable | 39.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.8 | |||||
| Shareholder Yield % | 0.28 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50.85 | |||||
| Operating Margin % | -7.42 | |||||
| Net Margin % | -7.85 | |||||
| FCF Margin % | 0.71 | |||||
| ROE % | -27.51 | |||||
| ROA % | -13.21 | |||||
| ROIC % | -15.07 | |||||
| 3-Year ROIIC % | 273.11 | |||||
| ROC (Joel Greenblatt) % | -17.18 | |||||
| ROCE % | -18.08 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 79.67 | |||||
| PS Ratio | 0.87 | |||||
| PB Ratio | 3.37 | |||||
| Price-to-Tangible-Book | 3.68 | |||||
| Price-to-Free-Cash-Flow | 119.5 | |||||
| Price-to-Operating-Cash-Flow | 43.45 | |||||
| EV-to-EBIT | -14.04 | |||||
| EV-to-EBITDA | -16.86 | |||||
| EV-to-Revenue | 1.02 | |||||
| EV-to-FCF | 144.37 | |||||
| Price-to-GF-Value | 1.17 | |||||
| Price-to-Median-PS-Value | 1.33 | |||||
| Price-to-Net-Current-Asset-Value | 11.95 | |||||
| Earnings Yield (Greenblatt) % | -7.12 | |||||
| FCF Yield % | 0.81 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ECIA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Encision Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 6.497 | ||
| EPS (TTM) ($) | -0.038 | ||
| Beta | 0.67 | ||
| 3-Year Sharpe Ratio | -0.02 | ||
| 3-Year Sortino Ratio | -0.03 | ||
| Volatility % | 73.52 | ||
| 14-Day RSI | 50.4 | ||
| 14-Day ATR ($) | 0.024737 | ||
| 20-Day SMA ($) | 0.4798 | ||
| 12-1 Month Momentum % | -30 | ||
| 52-Week Range ($) | 0.1172 - 0.7 | ||
| Shares Outstanding (Mil) | 11.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Encision Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Encision Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Encision Inc Frequently Asked Questions
What is Encision Inc(ECIA)'s stock price today?
The current price of ECIA is $0.48. The 52 week high of ECIA is $0.70 and 52 week low is $0.12.
When is next earnings date of Encision Inc(ECIA)?
The next earnings date of Encision Inc(ECIA) is .
Does Encision Inc(ECIA) pay dividends? If so, how much?
Encision Inc(ECIA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers